{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:05:27Z","timestamp":1780707927154,"version":"3.54.1"},"reference-count":46,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"abstract":"<jats:p>Recently published guidance on anticoagulation in people with hemophilia (PWH) appraised the literature on whether PWH are naturally anticoagulated: Only two studies compared thrombin generation (TG) in PWH and patients on vitamin K antagonists (VKA), analyzing endogenous thrombin potential (ETP), but were limited by stratifications. We compared TG between PWH A and patients with atrial fibrillation (AF) treated with VKA or direct oral anticoagulants (DOAC). TG was measured by a commercially available assay (Technothrombin), and DOAC levels by mass spectrometry. TG results were compared by equating separate linear regression models, avoiding stratification of the data. We included 565 samples from 110 PWH A, 118 VKA- and 113 DOAC-treated AF patients. TG parameters showed substantial variability among all cohorts, and, accordingly, their relationship with factor (F)VIII, INR, and DOAC levels and ability to differentiate between changes was modest. Importantly, TG curves clustered distinctly between cohorts, and different TG parameters led to varying comparison estimates. FVIII&lt;1 IU\/dL in PWH A corresponded to a mean INR-equivalence of 2.3 (95% CI, 2.2\u20132.5) and 2.0 (1.8\u20132.2); and a mean DOAC-equivalence of 229.0 (182.1\u2013279.6) and 284.2 (206.2\u2013358.0) ng\/mL rivaroxaban, 192.7 (123.0\u2013263.5) and 201.7 (73.8\u2013317.9) ng\/mL apixaban, and 313.0 (153.5\u2013448.1) and 242.3 (159.4\u2013328.7) ng\/mL dabigatran, using thrombin peak or ETP for estimation, respectively. TG showed substantial variability, differing systematically between PWH A, VKA-treated, and DOAC-treated AF patients. Our data call for caution when using TG to relate the hemostatic potential of PWH A to patients receiving oral anticoagulants and suggest comparisons by individual TG parameters to be overly simplistic.<\/jats:p>","DOI":"10.1055\/a-2882-3318","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:08:09Z","timestamp":1779836889000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of People with Hemophilia A and Patients with Nonvalvular Atrial Fibrillation on Oral Anticoagulation by Thrombin Generation"],"prefix":"10.1055","author":[{"given":"Daniel","family":"Kraemmer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Division of Hematology and Hemostaseology, Department of Medicine I"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Division of Hematology and Hemostaseology, Department of Medicine I"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Rejt\u0151","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Division of Hematology and Hemostaseology, Department of Medicine I"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Quehenberger","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Department of Laboratory Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Division of Hematology and Hemostaseology, Department of Medicine I"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"K\u00f6nigsbr\u00fcgge","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Austria","place":["Vienna"],"department":["Division of Hematology and Hemostaseology, Department of Medicine I"]},{"name":"Nagoya University Hospital, Aichi Prefecture, Japan","place":["Nagoya"],"department":["Department of Laboratory Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"E Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"V S Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2516.2011.02539.x","article-title":"Clinical severity of haemophilia A: does the classification of the 1950s still stand?","volume":"17","author":"I EM Den Uijl","year":"2011","journal-title":"Haemophilia"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"L A Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"A Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"S 01","key":"ref6","first-page":"6","article-title":"Mortality in congenital hemophilia A - a systematic literature review","volume":"19","author":"C RM Hay","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1538-7836.2011.04499.x","article-title":"Factor VIII deficiency does not protect against atherosclerosis","volume":"10","author":"S Biere-Rafi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1538-7836.2011.04514.x","article-title":"Coronary artery calcification score and carotid intima\u2013media thickness in patients with hemophilia","volume":"10","author":"M Zwiers","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/hae.14647","article-title":"Prevalence of comorbid conditions among older males with haemophilia receiving care in haemophilia treatment centers in the United States","volume":"28","author":"J M Soucie","year":"2022","journal-title":"Haemophilia"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"R G Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9921","key":"ref11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"C T Ruff","year":"2014","journal-title":"Lancet"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1097\/HS9.0000000000000900","article-title":"Antithrombotic treatment in patients with hemophilia: an EHA-ISTH-EAHAD-ESO clinical practice guidance","volume":"7","author":"R EG Schutgens","year":"2023","journal-title":"HemaSphere"},{"issue":"05","key":"ref13","first-page":"547","article-title":"Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability","volume":"88","author":"V Chantarangkul","year":"2003","journal-title":"Haematologica"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/jth.13674","article-title":"Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists","volume":"15","author":"M LY de Koning","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10238-018-0490-9","article-title":"Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation","volume":"18","author":"O K\u00f6nigsbr\u00fcgge","year":"2018","journal-title":"Clin Exp Med"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/hae.70085","article-title":"Estimating the factor VIII-equivalent activity of emicizumab using global assays of haemostasis","volume":"31","author":"D Kraemmer","year":"2025","journal-title":"Haemophilia"},{"key":"ref17","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2025"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Y Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.thromres.2008.09.011","article-title":"Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A","volume":"123","author":"J J van Veen","year":"2009","journal-title":"Thromb Res"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1538-7836.2007.02861.x","article-title":"Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype","volume":"6","author":"M Trossa\u00ebrt","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2516.2009.02190.x","article-title":"Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy","volume":"16","author":"R Gilmore","year":"2010","journal-title":"Haemophilia"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1538-7836.2007.02606.x","article-title":"Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapy","volume":"5","author":"R Altman","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.thromres.2015.10.026","article-title":"Thrombin generation and international normalized ratio in inherited thrombophilia patients receiving thromboprophylactic therapy","volume":"136","author":"H Luna-Z\u00e1izar","year":"2015","journal-title":"Thromb Res"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1365-2141.2008.07279.x","article-title":"Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic international normalized ratio is not due to inflammation","volume":"142","author":"A Gatt","year":"2008","journal-title":"Br J Haematol"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature","volume":"21","author":"J R Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jtha.2024.12.032","article-title":"Peak and trough concentrations of apixaban and rivaroxaban in adult patients: a systematic review and meta-analysis","volume":"23","author":"C A Almalbis","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/jth.15800","article-title":"Structural and cellular basis of vitamin K antagonism","volume":"20","author":"S Liu","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jth.15640","article-title":"Thrombin generation for monitoring hemostatic therapy in hemophilia A: a narrative review","volume":"20","author":"M JA Verhagen","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"S 02","key":"ref29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hae.13397","article-title":"Individualized PK-based prophylaxis in severe haemophilia","volume":"24","author":"Y Dargaud","year":"2018","journal-title":"Haemophilia"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2516.2005.01107.x","article-title":"Thrombin generation and phenotypic correlation in haemophilia A","volume":"11","author":"C P Beltr\u00e1n-Miranda","year":"2005","journal-title":"Haemophilia"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"100062","DOI":"10.1016\/j.rpth.2023.100062","article-title":"In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype","volume":"7","author":"M JA Verhagen","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"e12800","DOI":"10.1002\/rth2.12800","article-title":"Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes","volume":"6","author":"N Mathews","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1055\/a-2521-0923","article-title":"Influence of direct oral anticoagulant levels and thrombin generation on postoperative bleeding [SONAR]: a nested case-control study","volume":"125","author":"J R Shaw","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"109384","DOI":"10.1016\/j.thromres.2025.109384","article-title":"Thrombin generation assay in venous thromboembolism: a scoping review","volume":"252","author":"M EM Souza","year":"2025","journal-title":"Thromb Res"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B","volume":"232","author":"I M Nilsson","year":"1992","journal-title":"J Intern Med"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"S J Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"M R Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"C B Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"J P Bassand","year":"2021","journal-title":"Blood Adv"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.1016\/j.blre.2021.100852","article-title":"Optimising prophylaxis in haemophilia A: the ups and downs of treatment","volume":"50","author":"E Berntorp","year":"2021","journal-title":"Blood Rev"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjh.14084","article-title":"Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists","volume":"174","author":"D A Fitzmaurice","year":"2016","journal-title":"Br J Haematol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.sipas.2023.100230","article-title":"Association between direct oral anticoagulant concentrations and clinical outcomes: a systematic review and meta-analysis","volume":"15","author":"B Stretton","year":"2023","journal-title":"Surg Pract Sci"},{"issue":"09","key":"ref43","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/bloodadvances.2019000849","article-title":"Laboratory monitoring of hemophilia A treatments: new challenges","volume":"4","author":"P J Lenting","year":"2020","journal-title":"Blood Adv"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/jth.13743","article-title":"Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH","volume":"15","author":"Y Dargaud","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH03-01-0027","article-title":"Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma","volume":"90","author":"T Siegemund","year":"2003","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jth.12997","article-title":"Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B","volume":"13","author":"K M Hansson","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2882-3318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:46:28Z","timestamp":1780706788000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2882-3318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1055\/a-2882-3318","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,26]]}}}